Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Inclusion Criteria:

• Patient is willing and able to provide assent and willing to complete all aspects ofthe study

• Patient's parent or legal guardian willing and able to provide consent

• Male or female patients 12 through 17 years of age (inclusive)

• Clinical diagnosis of either schizophrenia or bipolar I disorder

Exclusion Criteria:

• Use of other investigational drugs at the time of enrollment, or within 30 days or 5half-lives of enrollment, whichever is longer

• A positive test for drugs of abuse